Profil
Richard A. F.
Dixon is the founder of 7 Hills Pharma LLC.
Prior to founding 7 Hills Pharma LLC, he worked as the Chief Scientific Officer & SVP-Research at Encysive Pharmaceuticals, Inc. from 1990 to 2011.
Before that, he was the Director & Head-Molecular Biology at Merck Sharp & Dohme Research Laboratories from 1988 to 1990.
Dixon received his undergraduate degree from Texas A&M University and his doctorate from Baylor College of Medicine.
Aktiva positioner av Richard A. F. Dixon
| Företag | Position | Start |
|---|---|---|
7 Hills Pharma LLC
7 Hills Pharma LLC Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer treatment | Grundare | - |
Tidigare kända positioner av Richard A. F. Dixon
| Företag | Position | Slut |
|---|---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Teknisk/Vetenskaplig/F&U Direktör | 2011-04-29 |
Merck Sharp & Dohme Research Laboratories | Direktör/Styrelseledamot | 1990-01-01 |
Richard A. F. Dixons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Health Technology |
Texas A&M University
Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Sharp & Dohme Research Laboratories | |
7 Hills Pharma LLC
7 Hills Pharma LLC Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer treatment | Health Technology |
















